Understanding and Responding to Outbreaks of HIV and Other Infections Among People Who Use Drugs
Predict, Detect, Diagnose: Confronting Outbreaks of HIV and Other Infectious Diseases Among People Who Use Drugs
This work helps us better understand, find, and quickly diagnose outbreaks of HIV and other infections that affect people who use drugs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11177859 on NIH RePORTER |
What this research studies
This project aims to develop new ways to predict, detect, and diagnose outbreaks of HIV, hepatitis C, and other infections that are common among people who use drugs. We want to create tools that help decision-makers identify areas at high risk for new outbreaks before they become widespread. By improving our ability to spot these outbreaks early, we can respond more quickly and effectively. This approach focuses on integrating different strategies to address outbreaks at various stages, ultimately helping to protect communities.
Who could benefit from this research
Good fit: This research is relevant to people who use drugs and are at risk for or affected by HIV, hepatitis C, sexually transmitted infections, or other related health issues.
Not a fit: Patients not at risk for or affected by HIV or other infectious diseases related to drug use may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to faster responses to infectious disease outbreaks, potentially preventing new infections and improving health outcomes for people who use drugs.
How similar studies have performed: This project builds on prior work in modeling and pattern recognition, suggesting a foundation of existing knowledge, but the integrated portfolio of methods is novel.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Gonsalves, Gregg Steven — Yale University
- Study coordinator: Gonsalves, Gregg Steven
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.